"The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach./"...
Emend Injection Consumer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
FOSAPREPITANT - INJECTION
COMMON BRAND NAME(S): Emend
USES: Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Fosaprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting.
This medication will not treat nausea or vomiting if you already have it. Contact your doctor for further instructions if you are experiencing nausea or vomiting.
HOW TO USE: Read the Patient Information Leaflet available from your pharmacist before you start using this medication and each time you get a refill or receive treatment. If you have any questions, consult your doctor or pharmacist.
This medication is given by injection into a vein by a health care professional. Fosaprepitant is usually given as a single dose 30 minutes before your chemotherapy or as directed by your doctor. On the following 2 days, you will usually take the form of this medication given by mouth (aprepitant). If you have any questions, consult your doctor or pharmacist.
Rarely, a very serious allergic reaction to this drug might occur while your dose is being given (infusion reaction). Tell your health care professional immediately if you experience any side effects such as flushing, redness, or trouble breathing during your treatment. The infusion may need to be stopped. If the infusion is stopped, tell your doctor about the infusion reaction and do not use fosaprepitant again.
Tell your doctor if you develop nausea or vomiting.
Additional Emend Injection Information
Emend Injection - User Reviews
Emend Injection User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.